Cell surface targeting accounts for the difference in iodide uptake activity between human Na+/I- symporter and rat Na +/I- symporter

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 11, 2005, Pages 6131-6140

  Zhang, Zhaoxia ^a   Liu, Yu Yu ^a   Jhiang, Sissy M ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODIDE; RADIOISOTOPE; SODIUM IODIDE SYMPORTER;

ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CELL SURFACE; CONTROLLED STUDY; GENETIC TRANSFECTION; KINETICS; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; TRANSGENE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; COS CELLS; HUMANS; IODIDES; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; RATS; SODIUM; SPECIES SPECIFICITY; STRUCTURE-ACTIVITY RELATIONSHIP; SYMPORTERS;

ANIMALIA;

EID: 27744455336     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-0895     Document Type: Article

References (39)

1. Reizer J, Reizer A, Saier Jr MH 1994 A functional superfamily of sodium/solute symporters. Biochim Biophys Acta 1197:133-166
2. - symporter. Mechanism, stoichiometry, and specificity. J Biol Chem 272:27230-27238
3. - symporter (NIS). Implications for its secondary structure model. J Biol Chem 273:22657-22663
4. De la Vieja A, Ginter CS, Carrasco N 2000 Topology of the sodium/iodide symporter. Program of the 12th International Thyroid Congress, Kyoto, Japan, p 162
5. Smanik PA, Liu Q, Furminger TL, Ryu K, Xing S, Mazzaferri EL, Jhiang SM 1996 Cloning of the human sodium iodide symporter. Biochem Biophys Res Commun 226:339-345
6. Dai G, Levy O, Carrasco N 1996 Cloning and characterization of the thyroid iodide transporter. Nature 379:458-460
7. Pinke LA, Dean DS, Bergert ER, Spitzweg C, Dutton CM, Morris JC 2001 Cloning of the mouse sodium iodide symporter. Thyroid 11:935-939
8. Selmi-Ruby S, Watrin C, Trouttet-Masson S, Bernier-Valentin F, Flachon V, Munari-Silem Y, Rousset B 2003 The porcine sodium/iodide symporter gene exhibits an uncommon expression pattern related to the use of alternative splice sites not present in the human or murine species. Endocrinology 144:1074-1085
9. Heltemes LM, Hagan CR, Mitrofanova EE, Panchal RG, Guo J, Link CJ 2003 The rat sodium iodide symporter gene permits more effective radioisotope concentration than the human sodium iodide symporter gene in human and rodent cancer cells. Cancer Gene Ther 10:14-22
10. Lee YJ, Chung J, Shin JH, Kang JH, Jeong JM, Lee DS, Lee MC 2004 In vitro and in vivo properties of a human anaplastic thyroid carcinoma cell line transfected with the sodium iodide symporter gene. Thyroid 14:889-895
11. Chung JK 2002 Sodium iodide symporter: its role in nuclear medicine. J Nucl Med 43:1188-1200
12. - symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid. Clin Cancer Res 10:4294-4302
13. Wapnir IL, van de Rijn M, Nowels K, Amenta PS, Walton K, Montgomery K, Greco RS, Dohan O, Carrasco N 2003 Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections. J Clin Endocrinol Metab 88:1880-1888
14. Marsee DK, Shen DH, MacDonald LR, Vadysirisack DD, Lin X, Hinkle G, Kloos RT, JhiangSM2004 Imaging of metastatic pulmonary tumors following NIS gene transfer using single photon emission computed tomography. Cancer Gene Ther 11:121-127
15. Miyagawa M, Beyer M, Wagner B, Anton M, Spitzweg C, Gansbacher B, Schwaiger M, Bengel FM 2005 Cardiac reporter gene imaging using the human sodium/iodide symporter gene. Cardiovasc Res 65:195-202
16. Niu G, Gaut AW, Ponto LL, Hichwa RD, Madsen MT, Graham MM, Domann FE 2004 Multimodality noninvasive imaging of gene transfer using the human sodium iodide symporter. J Nucl Med 45:445-449
17. Cho JY, Shen DH, Yang W, Williams B, Buckwalter TL, La Perle KM, Hinkle G, Pozderac R, Kloos R, Nagaraja HN, Barth RF, Jhiang SM 2002 In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas. Gene Ther 9:1139-1145
18. Spitzweg C, O'Connor MK, Bergert ER, Tindall DJ, Young CY, Morris JC 2000 Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter. Cancer Res 60:6526-6530
19. Boland A, Ricard M, Opolon P, Bidart JM, Yeh P, Filetti S, Schlumberger M, Perricaudet M 2000 Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. Cancer Res 60:3484-3492
20. Shen DH, Marsee DK, Schaap J, Yang W, Cho JY, Hinkle G, Nagaraja HN, Kloos RT, Barth RF, Jhiang SM 2004 Effects of dose, intervention time, and radionuclide on sodium iodide symporter (NIS)-targeted radionuclide therapy. Gene Ther 11:161-169
21. - symporter activity requires a small and uncharged amino acid residue at position 395. Mol Endocrinol 16:1893-1902
22. Furui T, LaPushin R, Mao M, Khan H, Watt SR, Watt MA, Lu Y, Fang X, Tsutsui S, Siddik ZH, Bast RC, Mills GB 1999 Overexpression of edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner. Clin Cancer Res 5:4308-4318
23. Wolfraim LA, Alkemade GM, Alex B, Sharpe S, Parks WT, Letterio JJ 2002 Development and application of fully functional epitope-tagged forms of transforming growth factor-β. J Immunol Methods 266:7-18
24. Castro MR, Bergert ER, Goellner JR, Hay ID, Morris JC 2001 Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake. J Clin Endocrinol Metab 86:5627-5632
25. Tonacchera M, Viacava P, Agretti P, de Marco G, Perri A, di Cosmo C, de Servi M, Miccoli P, Lippi F, Naccarato AG, Pinchera A, Chiovato L, Vitti P 2002 Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein. J Clin Endocrinol Metab 87:352-357
26. Pohlenz J, Duprez L, Weiss RE, Vassart G, Refetoff S, Costagliola S 2000 Failure of membrane targeting causes the functional defect of two mutant sodium iodide symporters. J Clin Endocrinol Metab 85:2366-2369
27. Kosugi S, Okamoto H, Tamada A, Sanchez-Franco F 2002 A novel peculiar mutation in the sodium/iodide symporter gene in Spanish siblings with iodide transport defect. J Clin Endocrinol Metab 87:3830-3836
28. Pohlenz J, Medeiros-Neto G, Gross JL, Silveira SP, Knobel M, Refetoff S 1997 Hypothyroidism in a Brazilian kindred due to iodide trapping defect caused by a homozygous mutation in the sodium/iodide symporter gene. Biochem Biophys Res Commun 240:488-491
29. Jung H 2002 The sodium/substrate symporter family: structural and functional features. FEBS Lett 529:73-77
30. +-coupled proline uptake. Biochemistry 36:4631-4636
31. +/solute symporter family. J Biol Chem 277:8790-8796
32. +/proline transporter of Escherichia coli. Biochemistry 38:13523-13529
33. +/proline transporter of Escherichia coli. Biochemistry 37:13800-13806
34. +/proline transporter PutP of Escherichia coli forms part of a conformationally flexible, cytoplasmic exposed aqueous cavity within the membrane. J Biol Chem 278:42942-42949
35. + and voltage dependence of the transporter. J Biol Chem 273:29341-29351
36. +/I symporter in patients with iodide transport defect. J Clin Endocrinol Metab 83:2940-2943
37. Kosugi S, Inoue S, Matsuda A, Jhiang SM 1998 Novel, missense and lossof-function mutations in the sodium/iodide symporter gene causing iodide transport defect in three Japanese patients. J Clin Endocrinol Metab 83:3373-3376
38. - symporter (NIS) function from analysis of a mutation that causes human congenital hypothyroidism. FEBS Lett 429:36-40
39. De la Vieja A, Ginter CS, Carrasco N 2004 The Q267E mutation in the sodium/iodide symporter (NIS) causes congenital iodide transport defect (ITD) by decreasing the NIS turnover number. J Cell Sci 117:677-687